1.
The Birth,
Early Years,
and Future of Interventional Radiology Josef Rösch,
MD,
Frederick S.
Keller,
MD,
and John A.
Kaufman,
MD J Vasc Interv Radiol 2003;14:841– 853.
2.
Margulis AR.
Interventional diagnostic radiology—a new subspecialty (Editorial).
AJR Am J Roentgenol 1967; 99:761–762.
3.
Antonio Basile,
Gianpaolo Carrafiello,
Anna Maria Ierardi,
Dimitrios Tsetis,
Elias Brountzos.
Quality-Improvement Guidelines for Hepatic Transarterial Chemoembolization.
Intervent Radiol DOI 10.1007/s00270-012-0423-z.
4.
Takayasu K,
Arii S,
Kudo M,
Ichida T,
Matsui O,
Izumi N,
et al.Superselective transarterial chemoembolization for hepatocellularcarcinoma.
Validation of treatment algorithm proposed by Japanese guidelines.J Hepatol 2012;56:886-92.
5.
Jemal A,
Bray F,
Center MM,
Ferlay J,
Ward E,
Forman D.
Global cancer statistics.CA Cancer J Clin 2011;61:69 –90.
6.
El Serag HB.
Hepatocellular carcinoma: recent trends in theUnited States.
Gastroenterology 2004; 127:S27-34.
7.
Fattovich G,
Stroffolini T,
Zagni I,
Donato F.
Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Gastroenterology 2004; 127:S35– 50.
8.
Berger DH,
Carrasco CH,
Hohn DC,
Curley SA.
Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications.
J Surg Oncol 1995;60: 116 –121.
9.
Brown DB,
Fundakowski CE,
Lisker-Melman M,
et al.
Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
J Vasc Interv Radiol 2004; 15:1209 –1218.
10.
Frangakis C,
Geschwind JF,
Kim D,
et al.
Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list.
Cardiovasc Intervent Radiol 2011; 34:1254 –1261.
11.
Bharat A,
Brown DB,
Crippin JS,
et al.
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
J Am Coll Surg 2006; 203:411– 420.
12.
Liu Y,
Yang R.
Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
J Vasc Interv Radiol 2009; 20:472–483.
13.
Miyayama S,
Yamashiro M,
Okuda M,
et al.
Chemoembolization for the treatment of large hepatocellular carcinoma.
J Vasc Interv Radiol 2010; 21:1226 –1234.
14.
Zhou B,
Shan H,ZhuKS,
et al.
Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation.
J Vasc Interv Radiol 2010;21:333–338.
15.
Llovet JM,
Bru C,
Bruix J.
Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Semin Liver Dis 1999;19:329–38.
16.
Llovet JM,
Bruix J.
Molecular targeted therapies in hepatocellularcarcinoma.
Hepatology 2008; 48:1312-27.
17.
Sorensen JB,
Klee M,
Palshof T,
Hansen HH.
Performance statusassessment in cancer patients.
Aninter-observer variability study.Br JCancer 1993;67:773–5.
18.
Llovet JM,
Real MI,
Montana X,
Planas R,
Coll S,
Aponte J,
et al.
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
Lancet.
2002;359:1734–1739.
19. Marelli L,
Stigliano R,
Triantos C,
Senzolo M,
Cholongitas E,Davies N,
et al.
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.
Cardiovasc Intervent Radiol 2007;30:6– 25.
20.
Takayasu K,
Arii S,
Kudo M,
Ichida T,
Matsui O,
Izumi N,
et al.
Superselective transarterial chemoembolization for hepatocellularcarcinoma.
Validation of treatment algorithm proposed by Japanese guidelines.J Hepatol 2012;56:886-92.
21.
Livraghi T,
Meloni F,
Di Stasi M,
Rolle E,
Solbiati L,
Tinelli C,
et al.
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82– 9.
22.
Thomas J.
Vogl,
Tatjana Gruber,
Jörn O.
Balzer,
Katrin Eichler,
Renate Hammerstingl,
and Stefan Zangos.
Repeated Transarterial Chemoembolization in the Treatment of Liver Metastases of Colorectal Cancer: Prospective Study Radiology January 2009 250:1 281-289; doi:10.1148/radiol.2501080295.
23.
Bramhall SR,
Gur U,
Coldham C,
et al.Liver resection for colorectal metastases.
Ann R Coll Surg Engl 2003; 85:334–339.
24.
Sanz-Altamira PM,
Spence LD,
Huberman MS,
et al.
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
DisColonRectum 1997; 40:770–775.
25.
Angle JF,
Nemcek AA Jr,
Cohen AM,
Miller DL,
Grassi CJ,
D'Agostino HR,
Khan AA,
Kundu S,
Osnis RB,
Rajan DK,
Schwartzberg MS,
Swan TL,
Vedantham S,
Wallace MJ,
Cardella JF; SIR Standards Division.
Quality improvement guidelines for preventing wrong site,
wrong procedure,
and wrong person errors: application of the joint commission "universal protocol for preventing wrong site,
wrong procedure,
wrong person surgery" to the practice of interventional radiology.
J Vasc Interv Radiol.
2009 Jul;20(7 Suppl):S256-62.
doi: 10.1016/j.jvir.
2009.04.023.
26. Daniel B.
Brown,
MD,
Boris Nikolic,
MD,
MBA,
Anne M.
Covey,
MD,
Charles W.
Nutting,
DO,Wael E.
A.
Saad,
MD,
Riad Salem,
MD,
MBA,
Constantinos T.
Sofocleous,
MD,
PhD,and Daniel Y.
Sze,
MD,
PhD.
Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization,
Embolization,
and Chemotherapeutic Infusion for Hepatic Malignancy.
J Vasc Interv Radiol 2012; 23:287–294.
27.
Geschwind JF,
Kaushik S,
Ramsey DE,
Choti MA,
Fishman EK,
KobeiterH.
Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors.
J Vasc Interv Radiol 2002; 13:1163–1166.
28. Patel S,
Tuite CM,
Mondschein JI,
Soulen MC.
Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention.
J Vasc Interv Radiol 2006; 17:1931–1934
29.
Leung DA,
Goin JE,
Sickles C,
Raskay BJ,
Soulen MC.
Determinants of postembolization syndrome after hepatic chemoembolization.
J VascInterv Radiol 2001; 12:321–326.